Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
CRISPR-SID: identifying EZH2 as a druggable target for de... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
CRISPR-SID: identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping
0
Authors
Thomas Naert
17 more
Thomas Naert
•
Dieter Tulkens
15 more
•
Kris Vleminckx
Published
September 1, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Cancer Oncology
Crispr
Druggability
Computational Biology
Show all topics
DOI
10.1101/595769
License
cc-no
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Cancer Oncology
Crispr
Druggability
Computational Biology
Show all topics
DOI
10.1101/595769
License
cc-no